Metformin in Breast Cancer: Time for Action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin in Breast Cancer: Time for Action

Published:2009-07-10 Issue:20 Volume:27 Page:3271-3273
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Goodwin Pamela J.¹,Ligibel Jennifer A.²,Stambolic Vuk³

Affiliation:

1. Samuel Lunenfeld Research Institute, Mount Sinai Hospital; and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

2. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard School of Medicine, Boston, MA

3. Division of Signaling Biology, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.22.1630

Reference19 articles.

1. Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions?

2. Targeting AMPK: A new therapeutic opportunity in breast cancer

3. Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and other anti‐diabetic medication use and breast cancer incidence in the Nurses' Health Studies;International Journal of Cancer;2024-03-22

2. Metformin and Cancer: Solutions to a Real-World Evidence Failure;Diabetes Care;2023-04-26

3. Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review);Oncology Reports;2022-11-07

4. Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells;Pharmaceuticals;2022-03-21

5. Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer;FEBS Open Bio;2021-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3